Market Research Reports- Consulting Analysis Crystal Market Research ENT and Bronchoscopy Devices Market | Page 2

Some of the key factors driving the ENT devices market are rising incidence of ENT related infections
and traumas, increased prevalence of geriatric population around the world, and growing awareness about
ENT disorders and their prevention and cure among the target population. According to the data revealed
by the (NIDCD) in 2016, the highest amounts of hearing loss disorders exist in the age group between 60
and 69. As per a study conducted by Action on Hearing Loss, in 2015, over 11 million people in UK were
living with some form of hearing loss, which amounts to one in every 6 persons in the UK. According to
the data revealed in 2016 by health direct, an information service supported by Government of Australia,
adults usually encounter 2 to 4 colds every year whereas, children usually get affected by cold 5 to 10
times in a year as they are less immune to cold causing viruses. Such high prevalence of common cold in
children and adults will favorably contribute to the growth of ENT devices market over the forecast
period. However, factors such as high cost and unfavorable reimbursement policies for hearing aids are
likely to hinder the growth of ENT devices market.
In 2016, hearing care devices dominated the global ENT and bronchoscopy devices market due to
development of technologically advanced cochlear implants and hearing aids. However, the surgical ENT
& bronchoscopy devices segment is projected to witness favorable growth during the forecast period,
primarily due to rising demand for ENT lasers and radiofrequency devices for the treatment of ENT
related disorders. In terms of end users, the hospitals & clinics segment held a dominant share of the
global market in 2016.
Request a sample copy of ENT and Bronchoscopy Devices Market Research Report @
https://www.crystalmarketresearch.com/report-sample/HC08188
U.S. dominated the North American ENT and bronchoscopy devices market in 2016 which can be
attributed to rising geriatric population which is more prone to ENT disorders and availability of
reimbursement for ENT surgeries. Emerging countries such as China and India in the Asia-Pacific region
will witness significant growth during the forecast period primarily due to growing prevalence of hearing
disorders and rising disposable income of the people.
Some of the key players operating in the global ENT devices and bronchoscopy market are Entellus
Medical, Inc., Sonova Holding AG, Olympus Corporation, OPTOMIC ESPANA S.A., Karl StorzGmbh&
Co. Kg, MED-EL, Hoya Corporation (Pentax Medical), Sivantos Pte. Ltd., Cochlear Limited, Medtronic
PLC, Oticon Medical, Endoservice, Maxer Endoscopy, Sopro-Comeg (Acteon Group), William Demant
Holding A/S, IntriCon Corporation, GN Store Nord A/S, Starkey Hearing Technologies, Smith &
Nephew PLC, and Johnson & Johnson (Acclarent, Inc.).
Key Findings of the Research Study: